An Employer-Based Cost-Benefit Analysis of a Novel Pharmacotherapy Agent for Smoking Cessation

Smoking and Carcinoma of the Lung

1950 • 1,909 citations

Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 1,630 citations

Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 1,343 citations

Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

2005 • 922 citations

Antidepressants for smoking cessation

2003 • 703 citations

Cost-effectiveness of the Clinical Practice Recommendations in the AHCPR Guideline for Smoking Cessation

1997 • 473 citations

The Health Care Costs of Smoking

1997 • 401 citations

Clonidine for smoking cessation

2004 • 247 citations

How much can business expect to profit from smoking cessation?,

1983 • 121 citations

Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial

2005 • 90 citations

The Financial Implications of Coverage of Smoking Cessation Treatment by Managed Care Organizations

2004 • 48 citations

Pharmacoeconomic Analysis of Smoking-cessation Interventions

1996 • 48 citations

Addressing tobacco in managed care: results of the 2003 survey.

2006 • 37 citations

Can you afford to hire smokers?

1981 • 34 citations

FDA Speeds Smoking Cessation Drug Review

2006 • 8 citations